ANGELA SINGLEY: Open Payments
NPI 1487649950 · CORBIN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$735 in 28 payments from 12 companies in 2025. Trend: 2023 $588 · 2024 $250 · 2025 $735
Food & beverage: $667Education: $68
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $173 |
| Novartis Pharmaceuticals Corporation | 5 | $134 |
| CSL Behring | 3 | $83 |
| Regeneron Healthcare Solutions, Inc. | 4 | $79 |
| SANOFI-AVENTIS U.S. LLC | 1 | $68 |
| Grifols USA, LLC | 2 | $54 |
| Genentech USA, Inc. | 1 | $32 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| GENZYME CORPORATION | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
Products named: DUPIXENT, AIRSUPRA, Rhapsido, Xembify, TEZSPIRE, FASENRA, Haegarda, Xolair.
Industry payments across KY — which companies pay providers there.
